In 2023, 49 new drugs (excluding vaccines and gene therapies) received their first approval in the United States, the European Union, and Japan. Among them, 40 drugs have specific mechanism of action targets. Among them, there are 12 novel targets that have not been previously approved for drug modulation. See Table 1
Table 1 Drugs approved in 2023 with novel mechanism of action targets (source: nature).
药 Drug | 种类 Categories | 作用靶点机制 Mechanism of action target | 靶点 Target | 治疗疾病 Cure disease | 批准 Approval |
Fezolinetant | 小分子抑制剂 Small-molecule inhibitor | Read More
Related News
Artificial Intelligence in Precision Cancer Care: Unlocking the Future of Personalized Oncology
Muhammad Farhan Khalid August 22, 2025 You may like
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation! Subscribe
Note: You can unsubscribe from the alerts at any time. Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation! Subscribe
Note: You can unsubscribe from the alerts at any time. Most popular
Apeloa Pharmaceutical releases first ESG
PharmaSources
May 12, 2025
Basic Concepts and Latest Trends in Radiation Biology: Emerging Insights and Future Directions
Sadia Ajmal
Sep 18, 2025
Methodology Validation in Chinese Pharmacopoeia 2025: How to Report Accuracy and Precision
Xing Xing
Sep 12, 2025
Digitalization in Procurement: From AI Forecasting to Blockchain Traceability
Saher Haider
Sep 19, 2025
|









(All Rights Reserved)